Indivumed, GmbH and Regeneron Pharmaceuticals Inc. signed an agreement providing Regeneron with access to Indivumed’s quality tissue sample and clinical and molecular data collection methods, to support the company’s cancer research programs.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
